Latest AI and machine learning research in oncology/hematology for healthcare professionals.
Invasive ductal carcinoma is a type of breast cancer that is one of the most frequent and aggressive forms of breast malignancy, necessitating accurate and timely diagnosis for effective treatment. Though considered the gold standard, traditional histopathological diagnosis is subject to inter-observer and intra-observer variability, potentially impacting patient outcomes. This study proposed an e...
Foundation models are increasingly used in medical imaging, yet their ability to extract reliable quantitative radiographic phenotypes of cancer across diverse clinical contexts lacks systematic evaluation. Here, we introduce TumorImagingBench, a curated benchmark comprising six public datasets (3,244 scans) with varied oncological endpoints. We evaluate ten medical imaging foundation models, repr...
Artificial intelligence (AI)-based systems are increasingly being used to assist radiologists in detecting breast cancer on mammograms. However, appl...
Musculoskeletal tumors present a diagnostic challenge due to their rarity, histological diversity, and overlapping imaging features. Accurate characte...
Due to the decreasing age of onset and the postponement of childbearing, there is a growing number of patients with endometrial carcinoma (EC) and end...
This paper explores how artificial intelligence (AI) is being woven into precision medicine for neuro-oncology, highlighting its ethical, clinical, an...
Breast cancer is a significant health issue for women, characterized by its high rates of mortality and sickness. However, its early detection is cruc...
OBJECTIVE: Accurate pathology reports are crucial for the diagnosis and treatment planning of cancer patients. However, these reports are prone to err...
OBJECTIVES: Decades of clinical and fundamental research advancements in oncology have led to significant breakthroughs such as early screening, targe...
OBJECTIVE: Ovarian cancer is the most deadly gynaecological malignancy. This study aims to generate a predictive model for prognosis and therapeutic r...
INTRODUCTION: A significant challenge in treating non-small cell lung cancer (NSCLC) is its inherent resistance to radiation therapy, leading to poor ...
BACKGROUND: Ductal Carcinoma In Situ (DCIS) can progress to ipsilateral invasive breast cancer (IBC) but over 75% of DCIS lesions do not progress if u...
BACKGROUND: Early detection of esophageal squamous cell carcinoma (ESCC) significantly improves survival rates, yet reliable biochemical biomarkers fo...
BACKGROUND: With the increasing use of computed tomography (CT) in clinical practice, greater attention is being paid to the radiation dose. There are...
BACKGROUND: Lymph node metastasis (LNM) is the most common route of metastasis in esophageal squamous cell carcinoma (ESCC), and the treatment of pati...
Cervical cancer is a prevalent malignancy affecting the female reproductive system and is recognized as a prominent factor to female mortality on a gl...
The tumor microenvironment (TME) significantly influences cancer prognosis and therapeutic outcomes, yet its composition remains highly heterogeneous,...
Despite growing clinical use of contrast-enhanced ultrasound (CEUS), inconsistency remains in the modality's role in clinical pathways for hepatocellu...
Pancreatic cancer is a highly aggressive malignancy with rising incidence and mortality rates, often diagnosed at advanced stages. Conventional imagin...
BACKGROUND: Hematogenous metastasis (HM) poses a significant challenge in the treatment and outcome of gastric cancer (GC). This study identified and ...